Zolmitriptan-D6

• CAT Number: R007151
• CAS Number: 1217644-84-2
• Molecular Formula: C16H21N3O2
• Molecular Weight: 293.4
• Purity: ≥95%
• Synonyms: (4S)-4-[[3-[2-(Dimethyl-d6-amino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone; BW-311C90-d6; Zomig-d6
• Storage: -20°C
• IUPAC Name: (4S)-4-[[3-[2-[bis(trideuteriomethyl)amino]ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
• InChI: InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1/i1D3,2D3
• InChIKey: ULSDMUVEXKOYBU-MYLWHKILSA-N
• SMILES: [2H]C([2H])([2H])N(CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3)C([2H])([2H])[2H]

Zolmitriptan-d6 is a deuterated analog of zolmitriptan, where six hydrogen atoms are replaced with deuterium. This isotopically labeled compound is utilized in pharmaceutical research to study the metabolism, pharmacokinetics, and pharmacodynamics of zolmitriptan, a medication commonly used to treat migraines. The deuterium labeling allows for precise tracking and quantification using analytical techniques such as mass spectrometry, providing enhanced stability and accuracy in the analysis of the drug’s behavior within biological systems. Zolmitriptan-d6 is a valuable tool for researchers exploring the therapeutic mechanisms and safety profile of zolmitriptan, contributing to the optimization of migraine treatment strategies and drug development efforts.